A diagnostic specimen shipment is a patient sample, a tube of blood, a swab, a biopsy, a urine or stool container, packed and moved from where it was collected to the lab that will test it. It counts as a biological substance under transport rules the moment it leaves the clinic, because any human sample can carry an infectious agent even when the person it came from is not known to be sick. The packaging and the temperature both follow from that one fact.
Most routine samples move this way every day: a blood draw for a chemistry panel, a nasal swab for a respiratory test, a stool sample for a gut panel. The system built to move them looks nothing like general parcel shipping, because the packaging is regulated as dangerous goods and the clock on some analytes starts running the moment the sample leaves the patient.
UN3373 and the triple packaging system
Most diagnostic specimens travel under UN3373, Biological Substance Category B, the classification for samples with a low probability of containing a dangerous pathogen. The packaging rule under that classification is triple packaging: a primary receptacle holding the sample, a secondary packaging that is leakproof and lined with enough absorbent material to soak up the full contents if the primary container fails, and a rigid outer packaging carrying the UN3373 label and the shipper's and receiver's details. Each layer is built to contain a failure in the layer inside it, independently.
Category B is not the top of the scale. Samples known or suspected to contain a high-consequence pathogen are classified and packaged to a stricter standard entirely, Category A, under different UN numbers and far tighter packaging and carrier requirements. Almost no routine clinical specimen qualifies for that category, and treating an ordinary blood draw as though it did would be solving a problem the triple packaging system already handles.
Ambient, chilled, or frozen, decided by the assay
The temperature a specimen travels at is set by what is being tested for, not by the sample type. Many routine chemistry and serology assays tolerate ambient temperature for a day or so, because the analyte is stable enough that a short delay at room temperature does not change the result. Other assays do not have that margin: certain hormone panels, some coagulation tests, and most molecular and genetic testing need the sample chilled from the moment it is drawn, packed against gel packs to hold it in a cold band until it reaches the lab.
A smaller group of tests needs the sample frozen outright, usually because the analyte breaks down at any temperature above freezing or because the sample has been aliquoted for batch testing later. Deciding ambient, chilled, or frozen is a lab protocol question answered before the tube is ever drawn, and getting it wrong does not usually show up as a damaged sample. It shows up as a result the lab has to reject and repeat, which costs the patient more time than a cold pack would have.
Time to lab is the real constraint
Packaging format matters less than the interval between draw and arrival at the lab. Blood left too long before separation starts to hemolyze, some clotting factors degrade within hours regardless of temperature, and even a well-packed cold shipment fails its purpose if it sits at a courier depot overnight. The real constraint on diagnostic specimen transport is time to lab, and temperature control is one tool for managing that constraint, not a substitute for it.
This is why routing matters as much as packing. A specimen scheduled to reach a lab within a few hours can often travel at ambient temperature safely. The same specimen delayed by a day, through a longer courier route or an overnight hold, may need active cooling it would not otherwise require, purely because the time budget changed.
Courier networks and routing
Diagnostic specimens move through dedicated medical courier networks built around scheduled pickups rather than general parcel delivery: a courier runs a fixed loop between clinics, draw stations and a central lab several times a day, so a sample drawn in the morning reaches the lab the same afternoon. Reference lab send-outs, tests a local lab cannot run itself, travel further, usually overnight by air, to a specialist testing site.
Phlebotomists and clinic staff pack the specimen at the point of collection, couriers move it along the network, and receiving labs check the packaging and the time elapsed before accepting the sample for testing. Air carriers and freight forwarders apply the dangerous goods rules that govern UN3373 packaging, which is why the courier and the packaging standard are set by aviation and transport regulation as much as by lab protocol.
Dry ice for frozen aliquots
Samples that must travel frozen, banked aliquots for later batch testing, unstable analytes, some research and clinical trial specimens, travel packed in dry ice inside an insulated shipper built to vent the carbon dioxide gas the dry ice releases as it sublimates. That venting requirement adds a second dangerous goods classification on top of UN3373, since dry ice itself is regulated as a hazardous material for the gas it produces in an enclosed space.
Dry ice sublimates at a fixed rate, so the shipment has a finite hold time set by how much dry ice the box was packed with, the same limit that governs any dry ice shipment regardless of what is inside it. A frozen aliquot shipment planned against too short a transit window arrives with the dry ice gone and the sample already warming, which is why these shipments are planned around the transit time first and the packaging second.